67Indexed trials
mesh condition
Epilepsies, Partial
Intelligence
Epilepsies, Partial intelligence: 67 indexed trials, 13 recruiting studies, 40 sponsors across 60 countries.
13Recruiting
40Sponsors
60Countries
Leading sponsors
UCB Pharma80 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.60 recruiting
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.40 recruiting
Supernus Pharmaceuticals, Inc.31 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)31 recruiting
GlaxoSmithKline20 recruiting
UCB Pharma GmbH20 recruiting
Mid-Atlantic Epilepsy and Sleep Center, LLC20 recruiting
Great Ormond Street Hospital for Children NHS Foundation Trust21 recruiting
Mayo Clinic21 recruiting
SK Life Science, Inc.20 recruiting
University Hospital, Lille20 recruiting
Geographic activity
United States33trials
France13trials
Germany11trials
Spain9trials
Czechia9trials
Italy9trials
United Kingdom8trials
Mexico8trials
Bulgaria7trials
Poland7trials
Belgium6trials
Hungary6trials
Leading interventions
Levetiracetam4trials
topiramate3trials
pregabalin3trials
Lacosamide3trials
Topiramate2trials
XEN11012trials
levetiracetam2trials
Lamotrigine2trials
Andrews/Reiter behavioral treatment for epilepsy1trials
Brivaracetam1trials
Additional electrodes into bilateral anterior, centromedian and pulvinar thalamic nuclei1trials
40 mg/day vormatrogine for 12 weeks1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.